TEANECK, NJ, March 10, 2021 – Cognizant (Nasdaq: CTSH) is pleased to announce it has been named a Leader in the Everest Group PEAK Matrix® Assessment for Life Sciences Digital Services 2021. The new analyst report highlights Cognizant’s strong vision and growth strategy, expert thought leadership, and long-standing client partnerships across biopharmaceutical and medical device industries.
The report analyzed 27 IT service providers across the globe and recognized those organizations that demonstrated meaningful capabilities delivering next-generation life sciences digital services, future planning and technology expertise, and overall market adoption and impact of their solutions. Cognizant was highlighted in Everest Group’s Leader category and called out for the aforementioned strengths, as well as the company’s buildup of strategic acquisitions (including Zenith, Lev, and Code Zero) and noteworthy partnerships (including Medidata, Veeva, and AWS). Cognizant’s capabilities providing IoT transformation services, automation, and Software as a Medical Device (SaMD) all are areas that have helped the company become a Leader in this new report and in the field of digital transformation for clients.
“Cognizant is continually proving that its well-defined future vision and growth strategy for both biopharma and medical devices segments—along with its apt focus on mitigating challenges due to the COVID-19 pandemic—is enabling the company to support and future-proof its solutions for its clients,” said Chunky Satija Practice Director, Everest Group. “This strategic approach, combined with Cognizant’s expertise in implementing advanced technology to address the changing needs of this growing industry have enabled the company to stand out among its peers and establish itself as an innovative partner to clients.”
“We are pleased to be recognized by Everest Group for our valued client partnerships, expertise, and digital capabilities,” said Srinivas Shankar, Senior Vice President and Global Head for Cognizant's Life Sciences business. “As the life sciences industry continues to respond to changing global needs, Cognizant is continuing to co-innovate with our clients to deliver insight and solutions that drive operational efficiencies and help accelerate effective life-saving therapies to patients.”
Cognizant (Nasdaq-100: CTSH) is one of the world’s leading professional services companies, transforming clients’ business, operating, and technology models for the digital era. Our unique industry-based, consultative approach helps clients envision, build and run more innovative and efficient businesses. Headquartered in the U.S., Cognizant is ranked 194 on the Fortune 500 and is consistently listed among the most admired companies in the world. Learn how Cognizant helps clients lead with digital at www.cognizant.com or follow us @Cognizant.
For further information, contact: